16 June 2022 - A new treatment that increases the chance of a successful kidney transplant has been recommended by NICE in final draft guidance today.
Imlifidase (also known as Idefirix and made by Hansa Biopharma) has been recommended for people who are waiting for a kidney transplant and who are highly sensitised to human leukocyte antigens (HLAs) to prevent the body rejecting the donor organ.